HDAC3 and metabolic dysfunction-associated steatohepatitis: These SCFAs might combine with the GPR43 receptor and further inhibit the activation of the downstream HDAC3 and HMGB1/RAGE/NF-κB pathway, thereby alleviating NASH induced by a high AGE diet in rats.